No FOMO, Sanofi India looks to strengthen presence in rare disease, diabetes and haemophilia segments, says MD
Over the last 70 years, he said, about 200 trials have been done at 400-odd sites, and presently 18 are underway in future products in segments
Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].

